Page 32 - CIRN Annual Report 2017
P. 32

uenza
                    Research Network. Successful methodology for large-scale surveillance of severe
                JD Kellner, BL Coleman, SA McNeil, A McCarthy, G De Serres, on behalf of the
             JA Bettinger, I Rouleau, MC Gariépy, WR Bowie, L Valiquette, OG Vanderkooi,
                  Public Health Agency of Canada/Canadian Institutes for Health Research Infl





















                        2015;20(29):pii=21189.  requested.     6-8, 2016.  ON.                          4-6, 2015. Vancouver, BC.
                        events following influenza vaccination in Canada, 2011 and 2012. Euro Surveill.  K Wilson, KM Atkinson, J Westeinde. Apps for immunization – Leveraging  mobile devices to place the individual at the centre of care. Human Vaccine and  Immunotherapeutics 2015, 11(10):2395-9. J Westeinde, JA Bettinger, KM Atkinson, D Fergusson, K Marty, SL Deeks, N  Crowcroft, K Wilson. Proof of Concept: A Mobile Application that facilitates vaccine  adverse event reporting. Human










                                                                            Crowcroft, and J Bettinger. An evaluation of the feasibility and usability of a proof of
                                      CCfV Research Education Series Presentation, April 24, 2015. Halifax, Nova Scotia.
                            H MacDougall, L Monnais. Learning from the Past: History, MMR Immunization and
                         Research Network 1st Annual Meeting, May 6-7th, 2015. Montreal, Quebec. (Poster)
                                                 E Dubé. From hesitancy to acceptance: Effective strategies to communication with
                              the Emergence of Vaccine Hesitancy in Four Provinces. CIRN Social Sciences and
                                                          and policy challenges. Canadian Immunization Conference, December 2-4, 2014.
                       information on vaccine hesitant mother decision making. Canadian Immunization
                Canadian Immunization Research Network 1st Annual Meeting, May 6-7th, 2015.
                     M Vivion. My doctor is too pro, my chiro is too anti! The importance of balanced
                                    E Dubé. From Vaccine Hesitancy to Acceptance: A research Architecture. CIRN/
             K Zinszer et al. Surveillance of vaccination opinions and beliefs in online media.
                                           E Dubé. Defining vaccine hesitancy in Canada: Roots, determinants and scope.
                                                   vaccine-hesitant parents. Canadian Immunization Conference, December 2-4,
                                                        H MacDougall, L Monnais. Creating a national immunization schedule: History
                                                               E Dubé. Research on Vaccine Hesitancy in Canada. Oral presentation. CAIRE
                                                                          K Wilson, K Atkinson, J Westeinde, K Bell, K Marty, D Fergusson, S Deeks, N
                                 Humanities Network Annual Meeting, May 5, 2015. Montréal, Québec.
                                                                                concept mobile app for adverse event reporting post influenza vaccination. Human  JM Langley, DM MacDougall, BA Halperin, A Swain, SA Halperin, KA Top, SA  McNeil, D MacKinnon-Cameron, K Marty, G De Serres, E Dubé, JA Bettinger. Rapid  surveillance for health events following a mass meningococcal B vaccine program  in a university setting: A Canadian Immunization Research Network study. Vaccine  E Dubé, D










                  Montreal, Quebec.     (Webinar)    Best Brains Exchanges, February 3, 2015. Ottawa, Ontario.  2014. Ottawa, Ontario.  Ottawa, Ontario. (Poster) Annual Meeting, December 2, 2014. Ottawa, Ontario. CANADIAN NATIONAL VACCINE SAFETY NETWORK  Vaccines & Immuno 2016;12:1738-1748.  2016;34(34):4046-4049.  Quebec (Canada). Vaccine Reports 2016;6:29-35.  (Quebec). JA. Can J Infect Dis Med Microbiol. 2015;26(3):163.7  30
   27   28   29   30   31   32   33   34   35   36   37